The sudden end of the United States’ de minimis exemption has sent a jolt through global retail, e-commerce and logistics networks, forcing brands large and small to reprice, reroute and renegotiate overnight. What was once an obscure customs rule —… Read More ›
Uncategorized
End of India’s Betting App Boom and What the Ban Means for the Industry’s Future
India’s meteoric rise in real-money gaming apps—from fantasy sports to card games—has come to an abrupt halt with the government’s sweeping ban. Tracing its evolution and examining the fallout, this article explores how a once-thriving sector was built up, how… Read More ›
Goldman Sachs Leverages Market Volatility and Deal Flow to Outpace Profit Projections
Goldman Sachs reported second‑quarter net income of $3.7 billion, or $10.91 per share, comfortably above analysts’ $9.53‑per‑share consensus. The unexpected strength was driven by record revenues in both equities and debt trading, a rebound in advisory fees, and robust net interest… Read More ›
Air India Investigations into Ahmedabad Crash Probe Uncovers Deep‑Rooted Procedural and Oversight Gaps
A preliminary inquiry into last month’s Boeing 787 Dreamliner crash in Ahmedabad has surfaced a suite of unresolved issues surrounding cockpit protocols, maintenance oversight and regulatory coordination. Air India’s CEO Campbell Wilson warned staff that while the early findings offer… Read More ›
US Eliminates Prescriptive Daily Alcohol Limits to Reflect Evidence Uncertainty
The long‑standing recommendation that adults restrict their alcohol intake to one drink per day for women and two for men is set to disappear from the forthcoming U.S. Dietary Guidelines, reflecting growing questions about the scientific basis for specific daily… Read More ›
U.S.–China Tariffs Push Global Supply Chains to the Brink, New Data Reveals
A recent upsurge in trade tensions between Washington and Beijing has rattled manufacturers worldwide, driving supply chains to their most precarious state in years. Data compiled from thousands of firms indicates that orders and production in Asia and North America… Read More ›
Eli Lilly’s Lawsuit Against Telehealth Startups: Legal and Industry Implications
Eli Lilly, a leading pharmaceutical company, has filed lawsuits against four telehealth startups for allegedly selling knockoff versions of its GLP-1 medications Mounjaro and Zepbound. These medications, essential for treating obesity and diabetes, generated over $16.4 billion in revenue for… Read More ›
Trump’s Direct Involvement in Japan Tariff Talks Signals High-Stakes Negotiations
President Donald Trump’s unexpected participation in the initial trade discussions with Japan underscores the administration’s prioritization of these negotiations. By personally engaging in what was anticipated to be preliminary talks, Trump has elevated the importance of reaching a swift resolution…. Read More ›
New Study Links Maternal Diabetes to Higher Risk of Autism
A comprehensive new study has shed light on a growing concern in maternal and child health: the link between diabetes during pregnancy and an elevated risk of neurodevelopmental disorders in children. The research, which pooled data from over 200 earlier… Read More ›
Market Optimism Amid Trade Uncertainty: Global Equity Inflows Overlook Tariff Fears
Investor sentiment has taken an intriguing turn as global equity funds have seen record net inflows despite rising fears of an escalating trade war. In a week marked by heightened tariff threats from President Donald Trump—who has announced plans for… Read More ›